BackgroundThis study explored the diagnostic power of preoperative circulating tumor cells (CTCs) for the presence of microvascular invasion (MVI) and the relationship between dynamic changes in postoperative CTCs and prognosis.MethodsA total of 137 patients were recruited for the study. Preoperative blood samples were collected from all patients to detect CTCs. The time points for blood collection were before the operation, during the operation, and at 1 week, 1 month, 2 months, 3 months, 6 months, and 1 year after surgery. The predictive power of CTC count for the presence of MVI was analyzed by receiver operating characteristic (ROC) curve analysis. According to recurrence status, 137 patients were divided into three groups: no recurrence, early recurrence, and non-early recurrence groups.ResultsA threshold CTC count of 5 showed the most significant power for predicting the existence of MVI. In multivariate analysis, the parameters of preoperative CTC count, alpha-fetoprotein (AFP) and tumor diameter were independent predictors of MVI (P< 0.05). A CTC count greater than or equal to 5 had better predictive value than AFP>400 mu g/L and tumor diameter>5cm. The number of intraoperative CTCs in the three groups did not increase compared to that before surgery (P>0.05). The number of CTCs in the nonrecurrence group and the non-early recurrence group decreased significantly 1 week after surgery compared with the intraoperative values (P< 0.001), although there was no significant difference in the early recurrence group (P=0.95). Patients with mean CTC count <greater than or equal to>5 had significantly worse long-term outcomes than those with mean CTC count <5 (P< 0.001).ConclusionThe preoperative CTC counts in the peripheral blood of patients with HCC are closely correlated with MVI. The intraoperative manipulation of the lesion by the surgeon does not increase the number of CTCs in peripheral blood. Surgical removal of the tumor decreases the number of CTCs. The persistence of CTCs at a high level (>= 5) after surgery suggests a risk of early recurrence.Clinical trial registrationRegistration number is ChiCTR-OOC-16010183, date of registration is 2016-12-18.
基金：
National Key Research and Development Program of China [2016YFC0106004]
第一作者单位：[1]Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhou Jiangmin,Zhang Zhiwei,Zhou Honghao,et al.Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma[J].BMC CANCER.2020,20(1):doi:10.1186/s12885-020-07488-8.
APA：
Zhou, Jiangmin,Zhang, Zhiwei,Zhou, Honghao,Leng, Chao,Hou, Bingwu...&Chen, Xiaoping.(2020).Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.BMC CANCER,20,(1)
MLA：
Zhou, Jiangmin,et al."Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma".BMC CANCER 20..1(2020)
